author-photo

Thierry Calmels

GlaxoSmithKline

33

Papers

937

Citations

Citation Trend

Filter By

Papers (20) Sort By

Journal Conference Others

Novel and highly potent histamine H3 receptor ligands. Part 3: an alcohol function to improve the pharmacokinetic profile.

2013 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (4)
Determination of the binding mode and interacting amino-acids for dibasic H3 receptor antagonists

2013 Bioorganic & Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (15)
Homology Model Versus X-ray Structure in Receptor-based Drug Design: A Retrospective Analysis with the Dopamine D3 Receptor.

2011 ACS Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (20)
Novel and highly potent histamine H3 receptor ligands. Part 1: withdrawing of hERG activity

2011 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (14)
Novel and highly potent histamine H3 receptor ligands. Part 2: Exploring the cyclohexylamine-based series

2011 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (8)
Synthesis and evaluation of amides surrogates of dopamine D3 receptor ligands

2010 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (7)
Refined Docking as a Valuable Tool for Lead Optimization : Application to Histamine H3 Receptor Antagonists

2008 Archiv Der Pharmazie
Show All
- Source
- Cite
- Save
Citations (36)
Aza) cyclohexanes carbonylated as ligands of D3 dopamine receptor

2007
Show All
- Source
- Cite
- Save
Citations (0)
Nouveau (aza) cyclohexanes carbonylés comme ligands récepteurs de la dopamine d3

2007
Show All
- Source
- Cite
- Save
Citations (0)
BF2.649, A NON-IMIDAZOLE INVERSE AGONIST/ANTAGONIST AT THE HUMAN HISTAMINE H3 RECEPTOR: PRECLINICAL PHARMACOLOGY

2006 Journal of Pharmacology and Experimental Therapeutics
Show All
- Source
- Cite
- Save
Citations (135)